NCT03570164View on ClinicalTrials.gov

Hemodynamics for Equi-MAC Anesthesia

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 18, 2018

Primary Completion Date

November 13, 2018

Study Completion Date

November 13, 2018

Conditions
Anesthesia
Interventions
DRUG

Sevoflurane

End-tidal concentration of sevoflurane is maintained at age-corrected 1.0 minimum alveolar concentration throughout the study period.

DRUG

Desflurane

End-tidal concentration of desflurane is maintained at age-corrected 1.0 minimum alveolar concentration throughout the study period.

Trial Locations (1)

03181

Kangbuk Samsung Hospital, Seoul

All Listed Sponsors
lead

Kangbuk Samsung Hospital

OTHER

NCT03570164 - Hemodynamics for Equi-MAC Anesthesia | Biotech Hunter | Biotech Hunter